5 Top Gene Therapy Companies from Newt Gingrich and Marc Lichtenfeld 2019 Health and Wealth Summit, July 18, 2019

By ncbergst, July 20, 2019

Hello Fellow Irregulars! Did anyone watch the 2019 Health and Wealth Summit last Thursday with Newt Gingrich and Marc Lichtenfeld focused on the burgeoning gene therapy treatments in the health industry? Marc Lichtenfeld advertised the top 5 gene therapy companies and how to ”play them” in ”The Complete Gene Therapy Profit Guide” that is part of his Lightning Trend newsletter but at a non-refundable $2200 a year which I can’t afford. Anybody know the companies? Thanks!

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

12
Share your thoughts...

avatar
8 Comment threads
4 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
8 Comment authors
big tunancbergstncbergstKarl Welschmonedas Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Bruce N. Goren
Guest
Bruce N. Goren

I gave up waiting for the names after about 30 minutes of scammish promotional double-speak. I’m certain I’ll be spammed for weeks by these guys trying to get me to subscribe which I won’t. I stuck around only long enough to hear him describe the first company as being in the $50 dollar range and poised to jump soon as the next Abbott Labs or Novartis. This kind of promotion is usually a pump and dump so I don’t even care what the five tickers are now, though I did pose the question to Google and landed on your site… Read more »

Fred J
Guest
Fred J

No but I wish I did

ncbergst
Guest
ncbergst

Hi Fred, actually you only missed some informational advertising. It was interesting, but no actionable info was provided.

Michael B
Guest
Michael B

I (unfortunately) wasted an hour and a half listening to the broadcast in its entirety with pen in hand. It was strictly a promotional waste of time as it was a total ad for signing up for the latest gimmick. I was so mad at the end and angered that Newt would allow himself to be used in such a blatant gimmick (wonder how fat his bank account got for prostituting himself like that). Went to the site link listed at the end thinking surely after all this we will be rewarded with the names of these 5 stocks for… Read more »

ncbergst
Guest
ncbergst

Hi Michael, I totally agree! I was very surprised that Newt would have been part of that, but maybe he just wanted to make sure that the positive news about the gene therapy medical breakthroughs were shared with a larger audience regardless of the investment side of it. Anyway, thanks for following up on the site link and sharing what you found!

ma9635
Member
👍0
ma9635

I watched for 15 minutes and concluded it was a hyper pitch and not worth continuing. But I am interested in speculating in gene therapy cos. Any suggestions re services that might be good in gene therapy area?

monedas
Member
👍0
monedas

Perhaps researching for companies that make up an ETF focused on biotech would lead for the top candidates (!?). (USA, Canadian, European, Asian) ETFs are known to always have a varied mix (large, medium & small cap) as they refresh their lists yearly, hint: watch for the evergreens, newcomers and deadbeats. From the main ETF biotech list, select those companies which are mainly into gene therapy by distilling/filtering the list, for example – how many “gene therapy” USPTO patents each has? hoping this helps and someone reports back. Thank you for sharing your comments, suggestions and ideas.

monedas
Member
👍0
monedas

For example, these are 2 NASDAQ Biotech ETFs: BIS & IBB.

Karl Welsch
Guest
Karl Welsch

I would strongly check on these three gene editing companies: EDIT, CRSP, and NTLA. Other gene related companies that I like are: MYGN, SGMO, and ILMN.

Karl Welsch
Guest
Karl Welsch

I recommend looking at EDIT, CRSP, NTLA, MYGN, SGMO, and ILMN.

big tuna
Member
👍92

I stuck my toe in the water with ARKG- Ark Genomics Revolution ETF